Cargando…
Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey
Introduction. A survey was sent to referring oncologists (ROs) to explore the reasons behind their referral patterns and perceptions of Phase I studies before and after being provided with outcome data from advanced colorectal cancer (ACRC) patients who participated in Phase I trials at the Royal Ma...
Autores principales: | Brunetto, Andre, Olmos, David, Arkenau, Hendrik-Tobias, Tan, Daniel, Yap, Timomy, de Bono, Johann, Barriuso, Jorge, Kaye, Stan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136213/ https://www.ncbi.nlm.nih.gov/pubmed/21772849 http://dx.doi.org/10.1155/2011/861401 |
Ejemplares similares
-
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
por: Postel-Vinay, S, et al.
Publicado: (2009) -
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience
por: Arkenau, H-T, et al.
Publicado: (2008) -
Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience
por: Olmos, D, et al.
Publicado: (2008) -
Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations
por: Saggese, Matilde, et al.
Publicado: (2013) -
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
por: Fontana, Elisa, et al.
Publicado: (2020)